Literature DB >> 26230883

Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.

Ang Li1, Yue Li2, Lupei Du1.   

Abstract

GPR120 receptor functions as a receptor for ω-3 fatty acid, involving regulating the secretion of gastrointestinal peptide hormone, adipogenesis, adipogenic differentiation and anti-inflammatory process and the like in the aspect of biological functions. In view that the dysfunction of GPR120 receptor is closely correlated with metabolic disorders, GPR120 may act as a novel potential therapeutic target for the treatment of obesity, insulin resistance, Type 2 diabetes and so on. Therefore, mounting scientists devote themselves to probing the molecular mechanism of the biological function of GPR120 receptor and their ligands for the treatment of impaired metabolic health. Herein, we summarize the mechanisms of signal transduction through GPR120 receptor, and discovery and development of GPR120 agonists thereof.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26230883     DOI: 10.4155/fmc.15.75

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  4 in total

1.  Therapeutic Potential of GPR120 Agonists for the Treatment of Type 2 Diabetes.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-10-16       Impact factor: 4.345

2.  Discovery of the First Environment-Sensitive Fluorescent Probe for GPR120 (FFA4) Imaging.

Authors:  Jiaxiang Liu; Chengsen Tian; Tianyu Jiang; Yuqi Gao; Yubin Zhou; Minyong Li; Lupei Du
Journal:  ACS Med Chem Lett       Date:  2017-03-27       Impact factor: 4.345

3.  GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.

Authors:  Gabriele Carullo; Sarah Mazzotta; Margarita Vega-Holm; Fernando Iglesias-Guerra; José Manuel Vega-Pérez; Francesca Aiello; Antonella Brizzi
Journal:  J Med Chem       Date:  2021-04-10       Impact factor: 7.446

4.  Label-free cell phenotypic study of FFA4 and FFA1 and discovery of novel agonists of FFA4 from natural products.

Authors:  Fangfang Xu; Han Zhou; Xiumei Liu; Xiuli Zhang; Zhiwei Wang; Tao Hou; Jixia Wang; Lala Qu; Pengyu Zhang; Hailong Piao; Xinmiao Liang
Journal:  RSC Adv       Date:  2019-05-15       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.